Jakub Rech

Jakub Rech is a Researcher at the Department of Biotechnology and Genetic Engineering, Medical University of Silesia, affiliated with the Faculty of Pharmaceutical Sciences in Sosnowiec. His current work focuses on combining hyperthermia and novel xanthone derivatives as a dual therapy for ovarian and breast cancers. He holds an ORCID identifier (0000-0002-3070-7993) and has published 28 papers, 1 promoted thesis, and achieved a Total MEiN score of 1,130.

Research interests include drug delivery systems (focusing on exosomes and polymers like PLGA), tissue engineering (using fibrin-based scaffolds), and cancer therapy (targeting metastasis mechanisms). He explores polymer degradation dynamics and thermal characterization of drug delivery devices. Key projects involve shape-memory polymers for glaucoma treatments and hot-melt extrusion for psychiatric drug formulations.

His work spans biomedical applications of synthetic polymers, anticancer agent development, and exosome-based nanomedicine. Collaboration networks include cross-disciplinary teams in materials science and oncology.